Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

front page

  • Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech
    February 3rd, 2022· 3.1 min·
    Quantum Computing Targets Improved Human Aging and Longevity in new Agreement between Allosteric Bioscience and Polaris Quantum Biotech

    February 3, 2022, Allosteric Bioscience, Inc., a company founded in 2021 to

  • PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
    January 5th, 2022· 1.9 min·
    PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies

    Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated

  • Quantum Cloud Growth and the Future of Computing
    November 3rd, 2021· 2.4 min·
    Quantum Cloud Growth and the Future of Computing

    Just a few years ago, truly viable and useful quantum computing was

  • PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million
    September 30th, 2021· 1.3 min·
    PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million

    PolarisQB, the Durham based developer of the world’s first drug discovery software

  • Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation
    July 8th, 2021· 1 min·
    Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation

    Last year Polarisqb  began our journey to revolutionize the world of drug

  • Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases
    June 4th, 2021· 2.5 min·
    Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases

    PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial

  • PolarisQB Announce Hiring of Pharmacologist Ian Reynolds
    May 10th, 2021· 2.2 min·
    PolarisQB Announce Hiring of Pharmacologist Ian Reynolds

    Polarisqb  is proud to add Dr. Ian Reynolds, a world renowned expert

  • PM 360 Recognizes PolarisQB as a 2020 Innovative Startup
    January 11th, 2021· 1.4 min·
    PM 360 Recognizes PolarisQB as a 2020 Innovative Startup

    PM 360 is one of the leading magazines in the pharmaceutical marketing world,

  • BioPharmaTrend.com Names PolarisQB a Notable Biotech Startup
    December 15th, 2020· 2.2 min·
    BioPharmaTrend.com Names PolarisQB a Notable Biotech Startup

    BioPharmaTrend.com is a leading blog covering the pharmaceutical sector with a focus

  • PolarisQB Named One of Seven Pharma Startups to Watch in 2021 by Startus Insights
    December 8th, 2020· 1.3 min·
    PolarisQB Named One of Seven Pharma Startups to Watch in 2021 by Startus Insights

    StartUs Insights, a leading research and consulting group focused on the global

12Next
Search
Recent Posts
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
  • Combinatorial Optimization vs. Physical Simulation January 19, 2025
  • Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats January 12, 2025
Categories
  • Blog (14)
  • News (43)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top